A narrow 10–7 vote ended GLP-1 coverage for state employees, citing high premium costs and a tight state budget.

The Garfield Re-2 school board on Wednesday discussed the rate of renewal of insurance with Emma Dahlin from Willis Towers ...

Preliminary study finds GLP-1 drugs (semaglutide, etc.) are associated with 10% fewer emergency visits and lower medication use for chronic migraine patients.

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Cost-effectiveness is highly price-sensitive; lower U.S. prices, particularly approaching European levels, shift semaglutide toward favorable value rather than a binary go/no-go determination. Patient ...

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%.

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

GLP-1s were first approved in 2005 for the treatment of Type 2 diabetes. Since then, more versions of the medication have hit ...

GLP-1 medications are everywhere, but what happens when appetite suppression meets a culture obsessed with thinness?

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients ...